RESUMEN
Sodium metavanadate (NaVO3 ) is a pentavalent vanadium compound used in the metal industry and dietary supplements; human exposure occurs through inhalation of fumes and dust and ingestion of NaVO3 -containing products. The objective of this study was to assess the potential immunotoxicity of NaVO3 . Female B6C3F1/N mice were exposed to 0-500 ppm NaVO3 in drinking water for 28 days and evaluated for effects on immune cell populations and innate, cellular-mediated, and humoral-mediated immunity. There was a decreasing trend in body weight (BW) and BW gain in NaVO3 exposed mice, with a decrease (p ≤ 0.05) in BW gain at ≥250 ppm, relative to control. Conversely, increasing trends in spleen weights and an increase (p ≤ 0.05) in the spleen:BW ratio at ≥250 ppm NaVO3 were observed. NaVO3 exposure altered antibody production against sheep red blood cells (SRBC). Antibody forming cells (AFC)/106 spleen cells exhibited a decreasing trend, with a decrease (p ≤ 0.05) at 500 ppm NaVO3 , concurrent with an increase in percent B cells. NaVO3 had no effect on the serum anti-SRBC IgM antibody titers or anti-keyhole limpet hemocyanin antibody production. Exposure to NaVO3 decreased the percentage of natural killer cells at all dose levels (p ≤ 0.05), with no effect on the lytic activity. NaVO3 altered T-cell populations at 500 ppm but had no effect on T-cell proliferative responses or the lytic activity of cytotoxic T cells. Collectively, these data indicate that NaVO3 exposure can adversely affect the immune system by inducing alterations in humoral-mediated immunity, specifically the AFC response, with no effect on cell-mediated or innate immunity.
Asunto(s)
Agua Potable , Ratones , Femenino , Humanos , Animales , Ovinos , Vanadatos/toxicidad , Ratones Endogámicos , Bazo , SodioRESUMEN
Vanadium is a ubiquitous environmental contaminant that exists in multiple oxidation states. Humans are exposed to vanadyl (V4+) and vanadate (V5+) from dietary supplements, food, and drinking water and hence there is a concern for adverse human health. The current investigation is aimed at identifying vanadium oxidation states in vitro and in vivo and internal concentrations following exposure of rats to vanadyl sulfate (V4+) or sodium metavanadate (V5+) via drinking water for 14 d. Investigations in simulated gastric and intestinal fluids showed that V4+ was stable in gastric fluid while V5+ was stable in intestinal fluid. Analysis of rodent plasma showed that the only vanadium present was V4+, regardless of the exposed compound suggesting conversion of V5+ to V4+ in vivo and/or instability of V5+ species in biological matrices. Plasma, blood, and liver concentrations of total vanadium, after normalizing for vanadium dose consumed, were higher in male and female rats following exposure to V5+ than to V4+. Following exposure to either V4+ or V5+, the total vanadium concentration in plasma was 2- to 3-fold higher than in blood suggesting plasma as a better matrix than blood for measuring vanadium in future work. Liver to blood ratios were 4-7 demonstrating significant tissue retention following exposure to both compounds. In conclusion, these data point to potential differences in absorption and disposition properties of V4+ and V5+ salts and may explain the higher sensitivity in rats following drinking water exposure to V5+ than V4+ and highlights the importance of internal dose determination in toxicology studies.
Asunto(s)
Vanadatos/farmacocinética , Compuestos de Vanadio/farmacocinética , Administración Oral , Animales , Carga Corporal (Radioterapia) , Agua Potable , Femenino , Jugo Gástrico/química , Absorción Gastrointestinal , Secreciones Intestinales/química , Hígado/metabolismo , Masculino , Oxidación-Reducción , Ratas Sprague-Dawley , Distribución Tisular , Toxicocinética , Vanadatos/administración & dosificación , Vanadatos/sangre , Vanadatos/toxicidad , Compuestos de Vanadio/administración & dosificación , Compuestos de Vanadio/sangre , Compuestos de Vanadio/toxicidadRESUMEN
In the root apoplasm, V(V) and V(IV) toxicity can be alleviated through redox and complexation reactions involving phenolic substances and the polyuronic components. In such context we report the role of polygalacturonic acid (PGA) on the reducing activity of caffeic acid (CAF) towards V(V). The redox reaction was particularly effective at pH 2.8 leading to the formation of oxidation products with redox activity towards V(V). An o-quinone was identified as the first product of the reaction which is further involved in the formation of CAF dimers. At pH ≥ 3.6 the redox activity decreased and a yield in V(IV) equal to 38, 31, 21 and 14% was found at pH 3.6, 4.0. 5.0 and 6.0 respectively compared with that obtained at pH 2.8. The redox reaction was faster in the presence of PGA and a higher yield of V(IV) was found in the 4.0-6.0 pH range with respect to the CAF-V(V) binary system. The higher efficiency of the redox reaction in the presence of PGA was related with the ability of PGA to bind V(IV). The biological significance of the redox reaction between CAF and V(V), as well as the role of PGA in such reaction, was established "in vivo" using triticale plants. Results showed that PGA reduced significantly the phytotoxic effects of the V(V)-CAF system.
Asunto(s)
Contaminantes Ambientales/toxicidad , Pectinas/metabolismo , Raíces de Plantas/metabolismo , Vanadatos/metabolismo , Vanadatos/toxicidad , Ácidos Cafeicos/química , Contaminantes Ambientales/metabolismo , Contaminación Ambiental/efectos adversos , Inactivación Metabólica , Oxidación-Reducción , Plantas/efectos de los fármacosRESUMEN
The purpose of this study was to define the toxic effects of vanadium on thymic development in broilers fed on diets supplemented with 0, 5, 15, 30, 45 and 60 mg/kg of vanadium for 42 days. We examined the changes of relative weigh, cell cycle phase, apoptotic cells, and protein expression of Bcl-2, Bax, and caspase-3 in the thymus by the methods of flow cytometry, TUNEL (terminal-deoxynucleotidyl transferase mediated nick end labeling) and immunohistochemistry. The results showed that dietary high vanadium (30 mg/kg, 45 mg/kg and 60 mg/kg) caused the toxic effects on thymic development, which was characterized by decreasing relative weigh, increasing G0/G1 phase (a prolonged nondividing state), reducing S phase (DNA replication) and proliferating index (PI), and increasing percentages of apoptotic thymocytes. Concurrently, the protein expression levels of Bax and caspase-3 were increased, and protein expression levels of Bcl-2 were decreased. The thymic development suppression caused by dietary high vanadium further leads to inhibitive effects on T lymphocyte maturity and activity, and cellular immune function. The above-mentioned results provide new evidences for further understanding the vanadium immunotoxicity. In contrast, dietary 5 mg/kg vanadium promoted the thymic development by increasing relative weigh, decreasing G0/G1 phase, increasing S phase and PI, and reducing percentages of apoptotic thymocytes when compared to the control group and high vanadium groups.
Asunto(s)
Inmunosupresores/toxicidad , Timocitos/efectos de los fármacos , Timo/efectos de los fármacos , Vanadatos/toxicidad , Factores de Edad , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Puntos de Control del Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Pollos , Replicación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Inmunosupresores/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Transducción de Señal/efectos de los fármacos , Timocitos/metabolismo , Timocitos/patología , Timo/metabolismo , Timo/patología , Factores de Tiempo , Vanadatos/metabolismo , Proteína X Asociada a bcl-2/metabolismoRESUMEN
Polyol mediated synthesized luminescent YVO(4):Eu(3+) nanoparticles (NPs) have been encapsulated in mesoporous silica nanoparticles (MSNs) using the sol-gel process. X-ray diffraction and Fourier transform infrared spectroscopy along with transmission electron microscopy confirm the encapsulation of the YVO(4):Eu(3+) NPs in the SiO(2) matrix. N(2) adsorption/desorption analysis confirms the mesoporous nature of the MSNs and YVO(4):Eu(3+)-MSNs. No significant quenching of the YVO(4):Eu(3+) luminescence is observed for YVO(4):Eu(3+)-MSNs. This nanocomposite has been tested as a potential drug carrier. Efficient loading of doxorubicin hydrochloride (DOX), a typical anticancer drug, is observed which reaches up to 93% in 8 mg ml(-1) of YVO(4):Eu(3+)-MSNs. pH sensitive release of DOX is observed, with 54% release for pH 4.3 and 31% in a physiological environment (pH 7.4). Both MSNs and YVO(4):Eu(3+)-MSNs nanocomposites do not show accountable toxicity to two cell lines, i.e. HeLa and MCF-7. However, as desired, toxicity is observed when cells are incubated with DOX loaded YVO(4):Eu(3+)-MSNs. Laser scanning confocal microscopy images confirm the uptake of the nanocomposite in both cell lines. The morphology of the cells (MCF-7) changes after incubation with DOX loaded YVO(4):Eu(3+)-MSNs, indicating an interaction of DOX with the cells. More cytotoxicity to both cell lines with â¼90% killing is observed due to the synergistic effect of magnetic fluid hyperthermia and chemotherapy using a biphasic suspension of superparamagnetic iron oxide magnetic nanoparticles and DOX loaded YVO(4):Eu(3+)-MSNs. In addition, an AC magnetic field triggers an enhanced drug release.
Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Doxorrubicina/administración & dosificación , Nanopartículas/uso terapéutico , Neoplasias/diagnóstico , Neoplasias/terapia , Antibióticos Antineoplásicos/farmacología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Doxorrubicina/farmacología , Portadores de Fármacos/química , Portadores de Fármacos/uso terapéutico , Portadores de Fármacos/toxicidad , Europio/química , Europio/uso terapéutico , Europio/toxicidad , Óxido Ferrosoférrico/química , Óxido Ferrosoférrico/uso terapéutico , Óxido Ferrosoférrico/toxicidad , Humanos , Hipertermia Inducida/métodos , Magnetismo/métodos , Nanopartículas/química , Nanopartículas/toxicidad , Dióxido de Silicio/química , Dióxido de Silicio/uso terapéutico , Dióxido de Silicio/toxicidad , Vanadatos/química , Vanadatos/uso terapéutico , Vanadatos/toxicidad , Itrio/química , Itrio/uso terapéutico , Itrio/toxicidadRESUMEN
In this study, the morphological and biochemical susceptibility of the rat brain to vanadium, in the form of sodium metavanadate, and the comparative ameliorative effect of Garcinia kola and kolaviron (G. kola extract), was examined. Brain regions examined were the cerebrum, cerebellum, hippocampus and the olfactory bulb. We showed that vanadium administration caused cellular vacuolation, congestion, and Purkinje cell degeneration and a marked reduction in myelin tracts. Biochemical tests revealed increased lipid peroxidation induced by vanadium, which was ameliorated with the administration of G. kola and kolaviron. Vanadium administration caused an increase in thiobarbituric acid-reactive substances (TBARS) in the cerebrum and hippocampus, whereas the administration of kolaviron resulted in a reduction of the TBARS level by 65.7 and 80%, respectively, in the regions aforementioned. Also, the administration of kolaviron resulted in an increased activity of superoxide dismutase (61.24%) in all brain regions assessed, when compared with the group administered vanadium alone. Results obtained from this study led to the conclusion that kolaviron reduces vanadium-induced oxidative stress in the brain.
Asunto(s)
Flavonoides/farmacología , Garcinia kola/química , Fármacos Neuroprotectores/farmacología , Extractos Vegetales/farmacología , Vanadio/toxicidad , Animales , Antídotos/aislamiento & purificación , Antídotos/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/patología , Flavonoides/aislamiento & purificación , Peroxidación de Lípido/efectos de los fármacos , Masculino , Fármacos Neuroprotectores/aislamiento & purificación , Síndromes de Neurotoxicidad/tratamiento farmacológico , Síndromes de Neurotoxicidad/etiología , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Vanadatos/administración & dosificación , Vanadatos/toxicidadRESUMEN
Vanadium can induce potent hypoglycemic effects in type 1 and type 2 diabetes mellitus animals, but toxic adverse effects have inhibited the translation of these findings. Administration of vanadate in a black tea decoction has shown impressive hypoglycemic effects without evidence of toxicity in short-term studies. The purpose of this study was to investigate the hypoglycemic action and the toxic adverse effects of a tea/vanadate (T/V) decoction in diabetic rats over a 14-month treatment period. Streptozotocin-induced type 1 diabetes mellitus rats were orally gavaged with 40 mg sodium vanadate in a black tea decoction only when blood glucose levels were greater than 10 mmol/L. Glycemic status and liver and kidney function were monitored over 14 months. All of the diabetic rats in this treatment group (n = 25) required treatment with the T/V decoction at the start of the study to reduce blood glucose levels to less than 10 mmol/L. Diarrhea was uncommon among the T/V-treated animals during the first week of T/V treatment and was absent thereafter. There was no evidence of liver or kidney dysfunction or injury. From 2 to 6 months, fewer animals required the T/V treatment to maintain their blood glucose levels. After 9 months of treatment, none of the diabetic animals required any T/V to maintain their blood glucose levels at less than 10 mmol/L. Oral administration of a T/V decoction provides safe, long-acting hypoglycemic effects in type 1 diabetes mellitus rats. The typical glycemic signs of diabetes were absent for the last 5 months of the study.
Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes , Té , Vanadatos/toxicidad , Vanadatos/uso terapéutico , Amilasas/sangre , Animales , Colesterol/sangre , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Ingestión de Líquidos/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Hemoglobina Glucada/análisis , Insulina/sangre , Islotes Pancreáticos/patología , Pruebas de Función Renal , Pruebas de Función Hepática , Masculino , Ratas , Ratas Sprague-Dawley , Té/toxicidad , Triglicéridos/sangreRESUMEN
The purpose of this study was to examine oxidative stress induced by dietary vanadium in the mucosa of different parts of intestine including duodenum, jejunum, ileum, and cecal tonsil. A total of 420 1-day-old avian broilers were divided into six groups and fed on a corn-soybean basal diet as control diet or the same basal diet supplemented with 5, 15, 30, 45, and 60 mg/kg vanadium as ammonium metavanadate. During the experimental period of 42 days, oxidative stress parameters were determined for both control and experimental groups. The results showed that malondialdehyde content was significantly higher (p < 0.05 or p < 0.01) in 30, 45, and 60 mg/kg groups than in control group. In contrast, the activities of superoxide dismutase, catalase, and glutathione peroxidase, and ability to inhibit hydroxyl radical, and glutathione hormone content were significantly decreased (p < 0.05 or p < 0.01) mainly in 45 and 60 mg/kg groups in comparison with those of control group. However, the abovementioned oxidative stress parameters were not significantly changed (p > 0.05) in 5 and 15 mg/kg groups. It was concluded that dietary vanadium in excess of 30 mg/kg could cause obvious oxidative stress in the intestinal mucosa, which could impact the antioxidant function of intestinal tract in broilers.
Asunto(s)
Intestinos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Vanadatos/toxicidad , Animales , Animales Recién Nacidos , Catalasa/metabolismo , Pollos , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Radical Hidroxilo/metabolismo , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Malondialdehído/metabolismo , Superóxido Dismutasa/metabolismo , Factores de Tiempo , Vanadatos/administración & dosificación , Vanadio/administración & dosificación , Vanadio/toxicidadRESUMEN
Selenium (Se) and vanadium (V) are contaminants commonly found in aquatic systems affected by wastes derived from fossil fuels. To examine their effects on a widely distributed species of amphibian, we exposed gray tree frogs (Hyla versicolor) to Se (as SeO2) or V (as NaVO3) in their diet from the early larval period to metamorphosis. Concentrations of Se in Se-enriched food were 1.0 (Se control), 7.5 (Se low), and 32.7 (Se high) µg/g dw. Concentrations of V in V-enriched food were 3.0 (V control), 132.1 (V low), and 485.7 (V high) µg/g dw. Although we observed bioaccumulation of both metals throughout the larval period, no effects on growth, survival, metabolic rate, or lipid content were observed. Se concentrations in tissues did not vary among life stages, neither in Se low nor Se high treatments, such that maximum accumulation had occurred by the mid-larval period. In addition, there was no evidence of depuration of Se in either the Se low or the Se high treatments during metamorphosis. A strikingly different pattern of accumulation and depuration occurred in V-exposed individuals. In treatments V low and V high, maximum body burdens occurred in "premetamorphs" (i.e., animals with developed forelimbs but in which tail resorption had not begun), whereas body burdens in animals having completed metamorphosis were much lower and similar to those in larvae. These results suggest that compared with Se-exposed animals, V-exposed animals were able to depurate a substantial amount of accumulated V during the metamorphic period. In an ecologic context, it appears that amphibians exposed to Se during the larval period may serve as a vector of the metal to terrestrial predators, yet potential transfer of accumulated V to predators would largely be restricted to the aquatic habitat.
Asunto(s)
Ranidae/crecimiento & desarrollo , Compuestos de Selenio/toxicidad , Vanadatos/toxicidad , Contaminantes Químicos del Agua/toxicidad , Análisis de Varianza , Animales , Larva/crecimiento & desarrollo , Larva/metabolismo , Metamorfosis Biológica/efectos de los fármacos , Ranidae/metabolismo , Selenio/metabolismo , Selenio/toxicidad , Compuestos de Selenio/metabolismo , Óxidos de Selenio , Vanadatos/metabolismo , Vanadio/metabolismo , Vanadio/toxicidad , Contaminantes Químicos del Agua/metabolismoRESUMEN
In the present work, in vivo ROS formation and the activity of antioxidant enzymes in the hippocampus and the cerebellum of sodium metavanadate (NaVO3) treated rats were studied. Rats were i.p. injected with 3 mg/kg bw/day (V1 group) or with 7.2 mg/kg bw/day of NaVO3 (V2 group) for 5 consecutive days. Results show that after only 5 days of NaVO3 exposure, reactive oxygen species formation and alteration of the oxidative defence system were observed. Vanadium-induced OH production was detected in cerebellum at the high dose. This result was confirmed by in situ ROS histochemical staining. Neither Cat nor Cu-Zn SOD activities showed changes while GSH/GSSG ratio, in both brain areas, was significantly decreased in NaVO3-treated groups. The present work indicates that the NaVO3 dose and the particular brain area constitution would be critical in the cellular and molecular oxidative mechanism of this element.
Asunto(s)
Antioxidantes/metabolismo , Cerebelo/efectos de los fármacos , Contaminantes Ambientales/toxicidad , Hipocampo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Vanadatos/toxicidad , Animales , Catalasa/metabolismo , Cerebelo/enzimología , Cerebelo/metabolismo , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Hipocampo/enzimología , Hipocampo/metabolismo , Inyecciones Intraperitoneales , Masculino , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismoRESUMEN
The work investigated the protective role of vitamin E on vanadium induced neurotoxicity. Three adult female rats were divided into three groups, A-C with each dam and her pups forming a group. Group A served as control. The dam in Group B was given 3mg/kg b.w./day of vanadium from PND 1 while the Group C dam were given 3mg/kg b.w./day of vanadium, for 14 days and 500mg/kg b.w. of vitamin E 72 hourly in the same time frame. The results showed that pups from Group B, exhibited behavioural deficits in most tests, a significant reduction in body weight gain and absolute brain weight; in addition immunohistochemistry showed reactive astrogliosis induced by vanadium exposure. All these findings were however attenuated in pups whose dam was exposed to vanadium and vitamin E depicting the significant protective effects of this antioxidant against vanadium. This study is novel in that both vanadium and vitamin E were introduced through the lactation route. We conclude that though caution remains essential in the posology of vitamin E, the management of lactating mothers who have been exposed to vanadium occupationally, environmentally or therapeutically with supplementation of this antioxidant may be beneficial at least in the short term to both mother and offspring.
Asunto(s)
Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Lactancia , Leche/metabolismo , Fármacos Neuroprotectores/farmacología , Síndromes de Neurotoxicidad/prevención & control , Vanadatos/toxicidad , Vitamina E/farmacología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Astrocitos/patología , Biomarcadores/metabolismo , Peso Corporal/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Encéfalo/fisiopatología , Femenino , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Inyecciones Intraperitoneales , Exposición Materna/efectos adversos , Actividad Motora/efectos de los fármacos , Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/patología , Síndromes de Neurotoxicidad/fisiopatología , Síndromes de Neurotoxicidad/psicología , Ratas , Factores de Tiempo , Vanadatos/administración & dosificación , Vanadatos/metabolismoRESUMEN
In the present work, we investigated the cytotoxicity of vanadium and the influence of zinc and selenium on vanadium-dependent cell damage in the BALB/c 3T3 cell culture. Treatment of cells for 24 hours with medium containing 50, 100 and 200 microM NaVO3 caused a significant decrease in the cell viability as measured by MTT test. Furthermore, the assays for reactive oxygen species (NBT reduction and phenol red oxidation) demonstrated the increase in superoxide and hydrogen peroxide production. In the cotreatment studies, the cells were exposed to NaVO3 (50, 100 and 200 microM) in the presence of nontoxic concentrations of ZnCl2 (5 microM) or Na2SeO3 (0.5 microM). Following 24 h incubation, the cell viability (assessed in MTT assay) and reactive oxygen species generation were evaluated. Our data suggest that zinc and selenium, in the concentrations mentioned above, provide no protection against adverse actions induced by sodium metavanadate at concentration levels of 50, 100 and 200 microM. To our knowledge, this is the first report from in vitro studies on interaction between pentavalent vanadium and trace elements that function as antioxidants: zinc and selenium.
Asunto(s)
Antioxidantes/farmacología , Cloruros/farmacología , Selenito de Sodio/farmacología , Vanadatos/toxicidad , Compuestos de Zinc/farmacología , Animales , Células 3T3 BALB , Supervivencia Celular/efectos de los fármacos , Medios de Cultivo/farmacología , Interacciones Farmacológicas , Ratones , Especies Reactivas de Oxígeno/metabolismo , Selenio/farmacología , Oligoelementos/toxicidad , Vanadio/toxicidad , Zinc/farmacologíaRESUMEN
Vanadium compounds have been well recognized for hypoglycemic effects, but questions remain on gastrointestinal disturbance and possible tissue vanadium accumulation thus slowing the acceptance of vanadium compounds as diabetic therapeutic agents. Our intestinal permeability and toxicity studies of vanadium compounds have suggested that the co-administration of vanadate with Salvia miltiorrhiza Bunge decoction could benefit the therapeutic use of hypoglycemic vanadium compounds. In the present paper, we tested the hypoglycemic effects of vanadate ingested in an aqueous extract of S. Bunge using a streptozocin (STZ)-induced diabetic rat model. Oral administration of vanadate in S. Bunge herbal decoction produced a stable (free of hypoglycemic shock) and long-lasting ( approximately 70day) control of blood glucose status. Effective protection of animal organs from hyperglycemic damage was also observed. As expected, the herbal extract significantly alleviated vanadium toxicity, i.e. GI stress and metal accumulation. In addition, the result suggesting that vanadium-induced amelioration of the diabetic state appears to be secondary to the preservation of a functional portion of the pancreatic beta-cells which initially survived STZ-toxicity. These studies provide new insight into the therapeutic treatment of diabetics with vanadium compounds.
Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/toxicidad , Hipoglucemiantes/uso terapéutico , Fitoterapia , Salvia miltiorrhiza/química , Vanadatos/toxicidad , Vanadatos/uso terapéutico , Animales , Biomarcadores , Peso Corporal/efectos de los fármacos , Ingestión de Líquidos/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Prueba de Tolerancia a la Glucosa , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/análisis , Extractos Vegetales/uso terapéutico , Extractos Vegetales/toxicidad , Ratas , Ratas Wistar , Vanadatos/metabolismoRESUMEN
Expression pattern of heat shock proteins (Hsp) 72/73 and glucose regulated protein (Grp) 94 was studied in liver, kidney and testis of rats injected with sublethal doses of ammonium metavanadate (5 mg/kg/day). In addition, some batches of animals were given green tea decoction, known to be rich in anti-oxidative compounds, as sole beverage in order to evaluate its protective properties. In control animals, the stress proteins expression was found to be organ-dependent: anti-Grp94 antibody revealed two bands at 96 and 98 kDa in kidney and liver whereas the 98 kDa band only was found in testis; anti-Hsp72/73 antibody revealed that the constitutive Hsp73 was present in all organs whereas the inducible Hsp72 was only present in kidney and testis. In kidney of vanadium-treated rats, Hsp73 was over-expressed by about 50% whereas Hsp72 was down-regulated by 50-80%. No such effects were observed in liver and testis. In liver and kidney of vanadium-treated rats, Grp94 was over-expressed by 50% and 150% respectively whereas no change was found in testis. In rats given green tea as sole beverage, the 96 kDa protein expression level in liver was reduced both in controls and in vanadium-treated animals. However, green tea drinking failed to prevent the vanadium-induced Hsp72 under-expression in kidney of vanadium-treated rats.
Asunto(s)
Proteínas HSP70 de Choque Térmico/biosíntesis , Proteínas del Choque Térmico HSP72/biosíntesis , Proteínas de la Membrana/biosíntesis , Té , Vanadatos/toxicidad , Animales , Antioxidantes/farmacología , Western Blotting , Electroforesis en Gel de Poliacrilamida , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Testículo/efectos de los fármacos , Testículo/metabolismo , Distribución TisularRESUMEN
Vanadium compounds are able to interact with living cells exerting a variety of biological effects. The pentavalent form is the most stable and toxic form of the element. In systems in vitro pentavalent vanadium is an effective genotoxic agent, inducing DNA damage and chromosome malsegregation at low doses. On the other hand, no adequate in vivo data are available for the characterization of the genotoxic hazard following oral intake, the most relevant route of human exposure. In this study, the genotoxic effects produced by the oral intake of sodium ortho-vanadate (Na(3)VO(4)) were investigated. Male CD-1 mice were treated for 5 weeks with a range of concentrations of Na(3)VO(4) in drinking water (0.75-1500 mg/l). Both micronuclei and primary DNA lesions as detected by comet assay were assessed in several tissues. Statistically significant increases of micronuclei in bone marrow were observed in mice receiving the two highest concentrations of Na(3)VO(4) (750 and 1500 mg/l). A significant increase of comet tail length was observed in splenocytes of mice receiving Na(3)VO(4) at 1500 mg/l, whereas no effect was observed in bone marrow and testis cells. No treatment-related effect on sperm chromatin structure or on testis cell population was observed. The determination of vanadium content in mouse tissues at the end of treatment highlighted a very low internal exposure, especially in soft tissues. Overall, the results obtained indicate that the genotoxic activity of pentavalent vanadium is expressed in vivo only following high dose exposure, possibly as a consequence of the poor bioavailability of the element.
Asunto(s)
Daño del ADN , ADN/efectos de los fármacos , Mutágenos/toxicidad , Vanadatos/toxicidad , Administración Oral , Animales , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/patología , Huesos/efectos de los fármacos , Huesos/metabolismo , Ensayo Cometa , ADN/análisis , Relación Dosis-Respuesta a Droga , Ingestión de Líquidos , Citometría de Flujo , Masculino , Ratones , Ratones Endogámicos , Micronúcleos con Defecto Cromosómico/inducido químicamente , Pruebas de Micronúcleos , Tamaño de los Órganos/efectos de los fármacos , Reticulocitos/efectos de los fármacos , Reticulocitos/patología , Espermatozoides/efectos de los fármacos , Espermatozoides/patología , Bazo/efectos de los fármacos , Bazo/patología , Testículo/efectos de los fármacos , Testículo/patología , Vanadatos/farmacocinética , Vanadio/análisis , Vanadio/metabolismo , Abastecimiento de AguaRESUMEN
Oral administration of vanadate has a strong hypoglycemic effect but results in toxic side effects like life-threatening diarrhea. Tea is known to have potent antidiarrhea effects. We investigated the potential of suspending the vanadate in a tea decoction to reduce the diarrheatic action of vanadate. A concentrated extract of Lichee black tea was, therefore, added to sodium orthovanadate. Streptozotocin (STZ)-induced diabetic rats were orally gavaged with vanadate suspended in water or in the tea decoction, or with the tea extract alone. Blood glucose levels were assessed daily over 11 weeks with levels greater than 10 mmol/L warranting therapeutic intervention. Both the vanadate/water and vanadate/tea solutions acutely reduced blood glucose. The tea extract alone had no effect. The majority of vanadate/water-treated rats developed diarrhea and mortality rates approached 40%. Vanadate/tea-treated diabetic rats experienced no diarrhea or mortality and liver and kidney analyses (plasma ALT and creatinine, blood urea nitrogen [BUN], and urine-specific gravity) were normal. Animals treated with vanadate/tea retained blood glucose levels less than 10 mmol/L for an average of 24 consecutive days without subsequent treatments. Cataract formation was completely prevented. The mechanism of action of vanadate may have involved beta-cell stimulation because vanadate/tea-treated diabetic rats exhibited normal plasma insulin levels. In summary, because of its long-lasting effects, oral administration, and lack of side effects, vanadate/tea represents a potentially important alternative therapy for an insulin-deficient diabetic state.
Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/toxicidad , Hipoglucemiantes/uso terapéutico , Té , Vanadatos/toxicidad , Vanadatos/uso terapéutico , Animales , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Catarata/epidemiología , Colesterol/sangre , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/mortalidad , Diarrea/epidemiología , Diarrea/mortalidad , Ingestión de Líquidos , Ingestión de Alimentos , Pruebas de Función Hepática , Masculino , Extractos Vegetales/uso terapéutico , Ratas , Ratas Sprague-Dawley , Triglicéridos/sangre , Vanadatos/farmacocinéticaRESUMEN
Vanadium and its derivatives are the well-known environmental pollutants. We obtained that ammonium vanadate suppressed the alkaline (AlP) and acid (AcP) phosphatases activity in the variety of tissues. Vanadate inhibited the enzymes that take part in phosphoryl transfer reactions. Successive concentration-dependent decrease in AlP and AcP activities by vanadate (0.1 mM-1 mM) has been obtained in rat nervous tissue. Moreover, the observed reduction in the sensitivity of the enzymes to vanadate ions becomes more pronounced at the transition from higher and relatively young regions of nervous system to its more ancient parts. Phosphoprotein phosphatase (PP) activity has also been inhibited in various structures of brain tissue; in spinal cord, however, vanadate in comparatively low concentrations (10 microM) caused a steep rise in the enzyme activity. Only at high concentration (1 mM) vanadate exert the effect of moderate inhibition. The possibility of the existence of phylogenetically different molecular forms of nervous tissue PPs differed by their sensitivity to vanadate was supported in our comparative examination.
Asunto(s)
Sistema Nervioso/metabolismo , Fósforo/metabolismo , Vanadio/toxicidad , Fosfatasa Ácida/metabolismo , Fosfatasa Alcalina/metabolismo , Animales , Masculino , Sistema Nervioso/efectos de los fármacos , Sistema Nervioso/enzimología , Fosfoproteínas Fosfatasas/metabolismo , Ratas , Distribución Tisular , Vanadatos/toxicidadRESUMEN
Two forms of the transmembrane human protein tyrosine phosphatase (PTP sigma), generated by alternative splicing, were identified by cDNA cloning and Northern hybridization with selective cDNA probes. The larger form of PTP sigma is expressed in various human tissues, human osteosarcoma, and rat tibia. The hPTP sigma cDNA codes for a protein of 1911 amino acid residues and is composed of a cytoplasmic region with two PTP domains and an extracellular region that can be organized into three tandem repeats of immunoglobulin-like domains and eight tandem repeats of fibronectin type III-like domains. In the brain, the major transcript of PTP sigma is an alternatively spliced mRNA, in which the coding region for the fibronectin type III-like domains number four to seven are spliced out, thus coding for a protein of 1502 amino acid residues similar to the rat PTP sigma and rat PTP-NE3. Using in situ hybridization, we assigned hPTP sigma to chromosome 6, arm 6q and band 6q15. The bacterial-expressed hPTP sigma exhibits PTPase activity that was inhibited by orthovanadate (IC50 = 0.02 microM) and by two bisphosphonates used for the treatment of bone diseases, alendronate (ALN) (IC50 = 0.5 microM) and etidronate (IC50 = 0.2 microM). In quiescent calvaria osteoblasts, micromolar concentrations of vanadate, ALN and etidronate stimulate cellular proliferation. These findings show tissue-specific alternative splicing of PTP sigma and suggest that PTPs are putative targets of bisphosphonate action.
Asunto(s)
Empalme Alternativo , Difosfonatos/toxicidad , Inhibidores Enzimáticos/efectos adversos , Proteínas Tirosina Fosfatasas/genética , Secuencia de Aminoácidos , Secuencia de Bases , Northern Blotting , Neoplasias Óseas/patología , Encéfalo/metabolismo , División Celular/efectos de los fármacos , División Celular/genética , Cromosomas Humanos Par 6/metabolismo , Clonación Molecular , Citoplasma/metabolismo , ADN Complementario/química , ADN Complementario/genética , ADN Complementario/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/genética , Humanos , Datos de Secuencia Molecular , Osteosarcoma/patología , Reacción en Cadena de la Polimerasa , Proteínas Tirosina Fosfatasas/efectos de los fármacos , Proteínas Tirosina Fosfatasas/metabolismo , ARN/genética , ARN/metabolismo , Células Tumorales Cultivadas , Vanadatos/toxicidadRESUMEN
Promoters of C3H/10T1/2 cell morphological transformation that elevate intracellular oxidant levels can be distinguished by a spectrum of induced gene expression, which includes the oxidant-responsive murine proliferin gene family. Proliferin transcripts were induced 40- to 100-fold by 20 microM ammonium metavanadate, 20-fold by 5 microM vanadium pentoxide but only three-fold by vanadium oxide sulfate. Consistent with its response to other oxidant chemicals, induction of proliferin by ammonium metavanadate was inhibited almost completely by the antioxidant N-acetylcysteine (8 mM). Ammonium metavanadate (5 microM), added as promoter in two-stage morphological transformation assays, amplified yields of Type II and Type III foci in monolayers of 20-methylcholanthrene-initiated C3H/10T1/2 cells. Ammonium metavanadate also induced formation of Type II foci in single-step transformation assays. The results suggest that pentavalent vanadium compounds could promote morphological transformation in C3H/10T1/2 cells by creating a cellular state of oxidative stress, sufficient to induce elevated expression of the proliferin gene family.
Asunto(s)
Transformación Celular Neoplásica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Vanadatos/toxicidad , Animales , Antioxidantes/farmacología , Autorradiografía , Northern Blotting , Línea Celular , Transformación Celular Neoplásica/genética , Daño del ADN/efectos de los fármacos , Daño del ADN/genética , ADN Complementario/genética , ADN Complementario/metabolismo , Densitometría , Regulación Neoplásica de la Expresión Génica/genética , Glicoproteínas/genética , Sustancias de Crecimiento/genética , Péptidos y Proteínas de Señalización Intercelular , Ratones , Estrés Oxidativo/genética , Prolactina , Regiones Promotoras Genéticas , ARN Mensajero/genética , ARN Mensajero/aislamiento & purificación , Transcripción Genética/efectos de los fármacos , Transcripción Genética/genética , Vanadatos/metabolismo , Microglobulina beta-2/genéticaRESUMEN
Six experiments have been conducted examining the interaction of dietary sodium chloride levels and vanadate toxicity in chicks. Increasing the dietary supplement of NaCl from 0.5 to 2.0% resulted in amelioration of vanadate toxicity, as measured by growth rate. The amelioration was found to reside in the chloride ion. Hepatic, renal, and femur vanadium concentrations were usually reduced at the higher levels of NaCl supplementation, but there was little correlation between these reductions and the reversal of vanadate toxicity.